| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9911f3ffb183144488431472d9039dfa |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1137 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-711
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 |
| filingDate |
1998-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6748ad9e3246370b75037f214d86f403
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df83cc6d8cd56ed45263eb44e6079e54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5080d30c1aa5eb6e1263732ec3a5e4ab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a428eecbfb0800fb0b1fcf9ffa964fb8 |
| publicationDate |
1999-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
DE-19814963-A1 |
| titleOfInvention |
MAPKAP Kinase 2 inhibitors and their use for anti-inflammatory therapy |
| abstract |
The invention relates to MAPKAP kinase 2 inhibitors and their use for anti-inflammatory therapy. Areas of application of the invention are medicine and the pharmaceutical industry. DOLLAR A According to the invention, MAPKAP kinase 2 inhibitors are used at the gene level, at the protein level and on the basis of a specific change in the intracellular localization of MAPKAP kinase 2. DOLLAR A The invention enables targeted therapy of the inflammatory response and can therefore be of fundamental importance for modern medicine. |
| priorityDate |
1998-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |